Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis | Zendy

Frank O. Richards | Zendy; Abel Eigege | Zendy; Emmanuel S. Miri | Zendy; M. Y. Jinadu | Zendy; Donald R. Hopkins | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Integration of mass drug administration programmes in Nigeria: the challenge of schistosomiasis

Author(s) -

Frank O. Richards,

Abel Eigege,

Emmanuel S. Miri,

M. Y. Jinadu,

Donald R. Hopkins

Publication year - 2006

Publication title -

bulletin of the world health organization

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.459

H-Index - 168

eISSN - 1564-0604

pISSN - 0042-9686

DOI - 10.2471/blt.06.029652

Subject(s) - mass drug administration , praziquantel , lymphatic filariasis , ivermectin , schistosomiasis , albendazole , onchocerciasis , medicine , environmental health , filariasis , immunology , veterinary medicine , surgery , population , helminths

Annual mass drug administration (MDA) with safe oral anthelminthic drugs (praziquantel, ivermectin and albendazole) is the strategy for control of onchocerciasis, lymphatic filariasis (LF) and schistosomiasis. District health officers seek to integrate treatment activities in areas of overlapping disease endemicity, but they are faced with having to merge different programmatic guidelines.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research